Cross-functional Team Leadership, Brand Strategy, Marketing Strategy, and Product Launch Planning: Lead 5–10-member, cross-functional team in the development of the brand strategy, marketing tactics, and launch plan for the commercialization of Zandelisib (an oral follicular lymphoma product) in 2023.Budget Management: Developed and manage the 5-year, $5M, cross-functional launch budget for Zandelisib.Deliverables, Marketing, and Communication: Selected and oversee the agency of record, which develops key promotional deliverables that prepare the market and support drug launch. This includes both digital and print collateral for patient/caregiver initiatives and health care provider (HCP) communications.Presentations and Leading Meetings: Present ideas in both large and small meetings, drawing on strong communication skills to clearly convey complex topics and obtain buy-in within the organization.Team Collaboration, Qualitative Research, and Business Insights: Collaborated closely with the commercial team to create interview guides for and conduct qualitative research projects, which identified market potential and key insights for Zandelisib.Strategic Partnerships: Worked with Japan-based partner (Kyowa Kirin) on marketing and market access, driving consensus on and establishing key objectives for brand/launch plans that informed market development, disease education, and tactical strategies.

Team Leadership and Budget Management: Directed a 4-person team in reimbursement, distribution, specialty pharmacy network, contracting, and payer operations for NERLYNX, an oral breast cancer treatment medication. Managed multimillion dollar budget.Influence Others, Decision-Making, and Consensus Building: Influenced decision-making and drove consensus with finance, legal, and executive teams on new solutions to improve market access services.Contract Management and Metric Tracking: Managed contracts with specialty pharmacies and group purchasing organizations. Tracked contractually required key metrics to assess pharmacies’ performance against one another.Case Management: Established case management support to follow up on unfilled prescriptions, improving patient fill rates.Patient Care Management, Vendor Sourcing, and Patient Satisfaction: Monitored the services provided by the reimbursement vendor and specialty pharmacies, ensuring proper and efficient management of patient cases. Recommended move to new reimbursement services vendor that provided integrated nursing patient support and better data visibility. This change led to significant annual savings and greater patient satisfaction.

In 2019, I was promoted to Senior Director of Marketing, overseeing a two-person team with accountability for Nurse Marketing, Social Marketing, and the Speaker’s Bureau. I worked with patient advocacy organizations, as well as with NCCN, NCODA and APSHO. In that position, I established a Patient Mentor program as a resource for new patients. I also directed programs supporting Patient Adherence, including specialty pharmacy training and texting.

I joined the company in 2016 as the Marketing Director, with a dual focus on building a market access strategy and patient marketing programs to support the launch of Neratinib, a treatment for breast cancer. I established a reimbursement hub, patient support services, and the SPP distribution network.As Marketing Director, I developed the blueprint to support a comprehensive Patient Compliance and Adherence program, transitioning patients from IV to oral therapies. I also established a promotional speaker's bureau, managing logistics, speaker selection, and content creation.

I received multiple promotions at this biopharmaceutical corporation, culminating in Director of Nexavar Global Strategy in 2014.As the Director, I led global brand planning activities for an oral oncology treatment for kidney, liver, and thyroid cancer, as well as new indications and line extensions. I was influential in the development of key commercial and brand development strategies. From 2013 to 2014, I served as the Director of Marketing, leading marketing activities supporting Nexavar indications in Hepatocellular and Renal Cell Carcinoma. I supervised a Customer Marketing Manager in the execution of key account plans and dedicated to developing a community of key opinion leaders.I also worked with Bayer Healthcare to build a strategic brand plan for Nexavar. From 2009 to 2013, I served as the Associate Director of Marketing, responsible for leading marketing activities related to Nexavar in the treatment of Hepatocellular Carcinoma. In that role, I led the production of marketing collateral, speaker bureau programs, and support materials for both nurses and patients.I established a non-branded disease awareness speaker’s bureau to improve the early identification of patients with Hepatocellular Carcinoma.I also developed an intervention structure and collateral materials for a nurse-based patient adherence program.

Clinical Research Trials involving biologics for cancer including alpha interferon and IL-2, in diseases including Hairy Cell Leukemia, and Renal Cell Carcinoma